This registry-based cohort study aimed to assess both the frequency of prescription of concomitant aspirin (ASA) and DOAC therapy as well as its effect on clinical outcomes in patients with AF or VTE.
Testing for antibodies to platelet factor 4 positive in 22 of 23 patients; treatment with platelet transfusion should be avoided.
Study authors assessed the effectiveness and safety of DOACs compared with warfarin in patients with valvular atrial fibrillation.
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
Researchers sought to assess the incidence of thrombotic complications in the second wave of patients with COVID-19, how many patients had diagnostic imaging for these complications, overall mortality, and then compared these outcomes with the first wave.
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain
Results of a rodent model show that fibrin-specific core-shell nanogels with a tissue-type plasminogen activator warrants more study as a treatment for patients with DIC.
Recommendations are presented for the prevention and treatment of venous thromboembolism in patients with cancer.
Researchers analyze platelet and neutrophil activation in COVID-19 patients and its association with venous thromboembolism.
Applying clinical prediction rules correctly when treating patients with venous thromboembolism in primary care was found to be associated with low failure rate.